Commentary · 8 Jun 2026
Conference abstractPublished 29 Nov 2017
Beneficial interaction between B vitamins and omega-3 fatty acids in slowing brain atrophy and cognitive decline in subjects with Mild Cognitive Impairment (MCI)
United Arab Emirates University, UAE University of Oxford, UK University of Cape Town, South Africa University of Oslo, Norway
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: Raised plasma homocysteine (tHcy) and low intake of omega-3 long chain fatty acids (FA) are risk factors for AlzheimerÃ?¢Ã?Â?Ã?Â?s disease (AD). In subjects with MCI the VITACOG trial showed that B-vitamin treatment reduced the brain atrophy rate and slowed cognitive decline. We now show that these effects of B-vitamins are influenced by baseline plasma omega-3 FA concentrations. Method: The effects of B vitamin intervention in VITACOG subjects was analysed according to baseline omega-3 FA (DHA and EPA) concentrations. Results: There was a significant interaction (P = 0.024) between B-vitamin treatment and plasma omega-3 FA on brain atrophy rates. In subjects with high omega-3 FA, B-vitamin treatment slowed the atrophy rate by 40% compared with placebo, whereas B-vitamins had no effect on atrophy in subjects with low omega-3 FA. A similar interaction was found between omega-3 FA and the beneficial cognitive effects of B-vitamin treatment: high baseline omega-3 FA levels enhanced the slowing of cognitive decline following B-vitamin treatment. Conclusion: The beneficial effect of B-vitamin treatment on brain atrophy and cognition was found only in subjects with high plasma omega-3 FA. The results highlight the importance of identifying subgroups likely to benefit in clinical trials. A clinical trial is needed to see if a combination of B-vitamins and omega-3 FA will slow conversion from MCI to AD.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Alzheimers Disease & Parkinsonism.
Perspective · 8 Jun 2026
Oxidative Stress and Its Role in Neuronal Degeneration: Mechanisms and Implications
Commentary · 8 Jun 2026
Understanding the Pathophysiology of Prion-Induced Dementia
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “A Oulhaj”
- BylineArticles whose byline prints “F Jerneren”
- BylineArticles whose byline prints “CA de Jager”
- BylineArticles whose byline prints “H Refsum”
- BylineArticles whose byline prints “AD Smith”